Antimicrobial peptides and pathogenic Neissera : experimental studies in mouse, man and rat
Author: Bergman, Peter
Date: 2005-09-09
Location: Samuelssonsalen, Karolinska Institutet, Campus Solna
Time: 9.15
Department: Institutionen för medicinsk biokemi och biofysik (MBB) / Department of Medical Biochemistry and Biophysics
View/ Open:
Thesis (975.5Kb)
Abstract
Antimicrobial peptides are important effector molecules of innate
immunity. In this thesis, the focus is on antimicrobial peptides of the
cathelicidin family, i.e. LL-37 in man, CRAMP in mouse and rCRAMP in rat.
Expression of these cathelicidins in tissues and cells has been analyzed,
and their functional relevance has been studied in relation to the human
bacterial pathogens Neisseria gonorrhoeae and Neisseria meningitidis.
A peptidelprotein extract was made from human colon mucosa and several antimicrobial peptides and proteins were identified by HPLC purification. We propose that this complex mixture of antimicrobial peptides and proteins provides a functional barrier protecting the human colon against invading microorganisms. One of the identified peptides, the human cathelicidin LL-37, is also expressed in cervical epithelial cells. Infection of these cells with Neisseria gonorrhoeae (gonococci) resulted in down-regulation of LL-37. Further, this peptide exhibited potent bactericidal activity against Neisseria gonorrhoea, suggesting that down-regulation of LL-37 may facilitate invasion of gonococci in the female genital tract.
The brain - on the other hand - is rarely infected, and the protective mechanisms remain to be fully elucidated. A peptidelprotein extract of rat brain was found to be active against bacteria. Depletion experiments showed that the cathelicidin rCRAMP accounted for a large portion of this activity. Using RT-PCR and Western blot analysis, rCRAMP was localized to distinct regions of the brain. In addition, rCRAMP was found to be a potent killer of the neuropathogenic bacterium Neisseria meningitidis.
Meningococcal infection was studied in mice expressing the human complement regulator CD46. These mice were found to be highly susceptible to meningococcal infection. After meningococcal challenge, bacteria were found in cerebrospinal fluid of CD46 mice, but not in control mice, demonstrating that CD46 is crucial for establishing meningococcal infection. Finally, the role of mouse CRAMP in meningococcal infection was investigated. By immunohistochemistry, CRAMP was detected in the blood brain barrier and meninges after infection. CRAMP-KO mice were used to evaluate the role of CRAMP in vivo. Bacterial crossing of the blood brain barrier occurred both in CRAMP-KO mice and in control mice. However, CRAMP-KO mice exhibited higher bacterial counts in blood, liver and spleen six hours post infection, demonstrating a non-redundant and early effect of CRAMP in meningococcal sepsis.
Considering the emerging bacterial resistance against conventional antibiotics, it is important to investigate novel ways of treating infections. Isolation of antimicrobial peptides from tissue extracts and a detailed understanding of their regulation, may lead to the development of novel strategies in the treatment of infectious diseases.
A peptidelprotein extract was made from human colon mucosa and several antimicrobial peptides and proteins were identified by HPLC purification. We propose that this complex mixture of antimicrobial peptides and proteins provides a functional barrier protecting the human colon against invading microorganisms. One of the identified peptides, the human cathelicidin LL-37, is also expressed in cervical epithelial cells. Infection of these cells with Neisseria gonorrhoeae (gonococci) resulted in down-regulation of LL-37. Further, this peptide exhibited potent bactericidal activity against Neisseria gonorrhoea, suggesting that down-regulation of LL-37 may facilitate invasion of gonococci in the female genital tract.
The brain - on the other hand - is rarely infected, and the protective mechanisms remain to be fully elucidated. A peptidelprotein extract of rat brain was found to be active against bacteria. Depletion experiments showed that the cathelicidin rCRAMP accounted for a large portion of this activity. Using RT-PCR and Western blot analysis, rCRAMP was localized to distinct regions of the brain. In addition, rCRAMP was found to be a potent killer of the neuropathogenic bacterium Neisseria meningitidis.
Meningococcal infection was studied in mice expressing the human complement regulator CD46. These mice were found to be highly susceptible to meningococcal infection. After meningococcal challenge, bacteria were found in cerebrospinal fluid of CD46 mice, but not in control mice, demonstrating that CD46 is crucial for establishing meningococcal infection. Finally, the role of mouse CRAMP in meningococcal infection was investigated. By immunohistochemistry, CRAMP was detected in the blood brain barrier and meninges after infection. CRAMP-KO mice were used to evaluate the role of CRAMP in vivo. Bacterial crossing of the blood brain barrier occurred both in CRAMP-KO mice and in control mice. However, CRAMP-KO mice exhibited higher bacterial counts in blood, liver and spleen six hours post infection, demonstrating a non-redundant and early effect of CRAMP in meningococcal sepsis.
Considering the emerging bacterial resistance against conventional antibiotics, it is important to investigate novel ways of treating infections. Isolation of antimicrobial peptides from tissue extracts and a detailed understanding of their regulation, may lead to the development of novel strategies in the treatment of infectious diseases.
List of papers:
I. Tollin M, Bergman P, Svenberg T, Jornvall H, Gudmundsson GH, Agerberth B (2003). Antimicrobial peptides in the first line defence of human colon mucosa. Peptides. 24(4): 523-30.
Fulltext (DOI)
Pubmed
View record in Web of Science®
II. Bergman P, Johansson L, Asp V, Plant L, Gudmundsson GH, Jonsson AB, Agerberth B (2005). Neisseria gonorrhoeae downregulates expression of the human antimicrobial peptide LL-37. Cell Microbiol. 7(7): 1009-17.
Fulltext (DOI)
Pubmed
View record in Web of Science®
III. Bergman P, Termen S, Johansson L, Nystrom L, Arenas E, Jonsson AB, Hokfelt T, Gudmundsson GH, Agerberth B (2005). The antimicrobial peptide rCRAMP is present in the central nervous system of the rat. J Neurochem. 93(5): 1132-40.
Fulltext (DOI)
Pubmed
View record in Web of Science®
IV. Johansson L, Rytkonen A, Bergman P, Albiger B, Kallstrom H, Hokfelt T, Agerberth B, Cattaneo R, Jonsson AB (2003). CD46 in meningococcal disease. Science. 301(5631): 373-5.
Fulltext (DOI)
Pubmed
View record in Web of Science®
V. Bergman P, Johansson L, Wan H, Gallo RL, Gudmundsson GH, Hokfelt T, Jonsson AB, Agerberth B (2005). Induction of the antimicrobial peptide mouse CRAMP in the blood brain barrier and meninges after meninggococcal infection. [Submitted]
I. Tollin M, Bergman P, Svenberg T, Jornvall H, Gudmundsson GH, Agerberth B (2003). Antimicrobial peptides in the first line defence of human colon mucosa. Peptides. 24(4): 523-30.
Fulltext (DOI)
Pubmed
View record in Web of Science®
II. Bergman P, Johansson L, Asp V, Plant L, Gudmundsson GH, Jonsson AB, Agerberth B (2005). Neisseria gonorrhoeae downregulates expression of the human antimicrobial peptide LL-37. Cell Microbiol. 7(7): 1009-17.
Fulltext (DOI)
Pubmed
View record in Web of Science®
III. Bergman P, Termen S, Johansson L, Nystrom L, Arenas E, Jonsson AB, Hokfelt T, Gudmundsson GH, Agerberth B (2005). The antimicrobial peptide rCRAMP is present in the central nervous system of the rat. J Neurochem. 93(5): 1132-40.
Fulltext (DOI)
Pubmed
View record in Web of Science®
IV. Johansson L, Rytkonen A, Bergman P, Albiger B, Kallstrom H, Hokfelt T, Agerberth B, Cattaneo R, Jonsson AB (2003). CD46 in meningococcal disease. Science. 301(5631): 373-5.
Fulltext (DOI)
Pubmed
View record in Web of Science®
V. Bergman P, Johansson L, Wan H, Gallo RL, Gudmundsson GH, Hokfelt T, Jonsson AB, Agerberth B (2005). Induction of the antimicrobial peptide mouse CRAMP in the blood brain barrier and meninges after meninggococcal infection. [Submitted]
Issue date: 2005-08-19
Rights:
Publication year: 2005
ISBN: 91-7140-428-7
Statistics
Total Visits
Views | |
---|---|
Antimicrobial ...(legacy) | 802 |
Antimicrobial ... | 181 |
Total Visits Per Month
October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | |
---|---|---|---|---|---|---|---|
Antimicrobial ... | 2 | 0 | 0 | 0 | 1 | 1 | 0 |
File Visits
Views | |
---|---|
thesis.pdf(legacy) | 1125 |
thesis.pdf | 274 |
thesis.pdf.txt(legacy) | 2 |
Top country views
Views | |
---|---|
United States | 397 |
China | 88 |
Sweden | 78 |
Germany | 71 |
South Korea | 17 |
United Kingdom | 12 |
Russia | 12 |
Finland | 11 |
Canada | 7 |
Vietnam | 7 |
Top cities views
Views | |
---|---|
Sunnyvale | 49 |
Ashburn | 46 |
Romeo | 36 |
Beijing | 29 |
Kiez | 27 |
Stockholm | 19 |
Shenzhen | 17 |
Seoul | 14 |
Hanoi | 7 |
London | 7 |